Analysis of Vancomycin-Resistant Enterococci in Hemato-Oncological Patients

Autor: Kristýna Hricová, Taťána Štosová, Pavla Kučová, Kateřina Fišerová, Jan Bardoň, Milan Kolář
Jazyk: angličtina
Rok vydání: 2020
Předmět:
Zdroj: Antibiotics, Vol 9, Iss 11, p 785 (2020)
Druh dokumentu: article
ISSN: 2079-6382
DOI: 10.3390/antibiotics9110785
Popis: Enterococci are important bacterial pathogens, and their significance is even greater in the case of vancomycin-resistant enterococci (VRE). The study analyzed the presence of VRE in the gastrointestinal tract (GIT) of hemato-oncological patients. Active screening using selective agars yielded VRE for phenotypic and genotypic analyses. Isolated strains were identified with MALDI-TOF MS, (Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry) their susceptibility to antibiotics was tested, and resistance genes (vanA, vanB, vanC-1, vanC2-C3) and genes encoding virulence factors (asa1, gelE, cylA, esp, hyl) were detected. Pulsed-field gel electrophoresis was used to assess the relationship of the isolated strains. Over a period of three years, 103 VanA-type VRE were identified in 1405 hemato-oncological patients. The most frequently detected virulence factor was extracellular surface protein (84%), followed by hyaluronidase (40%). Unique restriction profiles were observed in 33% of strains; clonality was detected in 67% of isolates. The study found that 7% of hemato-oncological patients carried VRE in their GIT. In all cases, the species identified was Enterococcus faecium. No clone persisted for the entire 3-year study period. However, genetically different clusters were observed for shorter periods of time, no longer than eight months, with identical VRE spreading among patients.
Databáze: Directory of Open Access Journals